Spots Global Cancer Trial Database for The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins
Official Title: Platelet Modulation in the Control of Angiogenesis: The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Activation and Angiogenic Proteins
Study ID: NCT01341171
Conditions
Interventions
Study Description
Brief Summary: Single phlebotomy study involving women receiving tamoxifen or aromatase inhibitor therapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Vermont, Burlington, Vermont, United States
Contact Details
Name: Chris E Holmes, MD, PhD
Affiliation: University of Vermont
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
